TrialLeukemia2020

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia.

M Fürstenau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.